Skip to main content

Risk magazine

Bank One casualties emerge

The first casualties from JP Morgan Chase’s upcoming purchase of Bank One – due to complete on July 5 – emerged last week with the news that both the Chicago-based bank’s foreign exchange heads in London are leaving, according to RiskNews’ sister…

DrKW recruits corporate repo and collateral trader

Glenn Handley has joined German investment bank Dresdner Kleinwort Wasserstein from Barclays Capital to work within the credit financing and collateral trading (CFCT) team, part of the short-term products and treasury group in London.

De Vitry warns of energy market regulatory pressures

Regulatory rules could adversely affect the development of a mature energy trading market, said Benoit de Vitry, global head of commodities and emerging markets rates at Barclays Capital in London, speaking at Energy Risk’s Houston conference.

Bayer signs up for SunGard Adaptiv

Bayer, the German pharmaceuticals and chemicals company, has chosen Sungard’s Adaptiv trading and risk management product to support its commodity, foreign exchange and fixed-income trading operations.

European power trading on the up, says Prospex report

European electricity trading volumes increased in 2003, with Germany seeing the biggest volumes, overtaking the Nordic region for the first time, according to a report from London-based Prospex Research, European Power Trading 2004 .

Deutsche loses top LatAm derivatives marketers

Deutsche Bank has lost two of its top derivatives marketers for Latin America. Hugo Faria, head of Latin American derivatives marketing and Mauricio Esquenazi, Faria’s deputy, have left for UBS and Credit Suisse First Boston, respectively.

Forex forwards head leaves Citigroup

Vincent de Lorenzo, head of foreign exchange forwards trading at Citigroup in New York, left the bank earlier this month, a source at Citigroup told RiskNews' sister publication, FX Week .

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here